ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $316,179 | -51.9% | 17,100 | -18.6% | 0.00% | 0.0% |
Q4 2023 | $657,510 | -11.7% | 21,000 | -41.2% | 0.00% | -66.7% |
Q3 2023 | $744,342 | +137.2% | 35,717 | +172.6% | 0.00% | +200.0% |
Q2 2023 | $313,745 | -47.2% | 13,100 | -58.5% | 0.00% | -50.0% |
Q1 2023 | $593,978 | +87.1% | 31,561 | +58.3% | 0.00% | +100.0% |
Q4 2022 | $317,381 | -38.7% | 19,936 | -37.0% | 0.00% | 0.0% |
Q3 2022 | $518,000 | +62.9% | 31,624 | +40.0% | 0.00% | 0.0% |
Q2 2022 | $318,000 | -66.3% | 22,582 | -42.1% | 0.00% | -50.0% |
Q1 2022 | $944,000 | -13.3% | 38,973 | -16.5% | 0.00% | -33.3% |
Q4 2021 | $1,089,000 | -15.1% | 46,649 | -39.6% | 0.00% | -25.0% |
Q3 2021 | $1,283,000 | +95.6% | 77,193 | +187.0% | 0.00% | +33.3% |
Q2 2021 | $656,000 | -88.6% | 26,901 | -80.0% | 0.00% | -92.3% |
Q4 2019 | $5,750,000 | +666.7% | 134,400 | +545.3% | 0.04% | +457.1% |
Q3 2019 | $750,000 | -62.6% | 20,826 | -72.3% | 0.01% | -58.8% |
Q2 2019 | $2,008,000 | +1047.4% | 75,100 | +595.4% | 0.02% | +1600.0% |
Q4 2018 | $175,000 | +8650.0% | 10,800 | +10700.0% | 0.00% | – |
Q3 2018 | $2,000 | -86.7% | 100 | -81.4% | 0.00% | – |
Q2 2017 | $15,000 | -96.6% | 538 | -95.8% | 0.00% | -100.0% |
Q1 2017 | $438,000 | +3550.0% | 12,728 | +3082.0% | 0.00% | – |
Q4 2016 | $12,000 | -36.8% | 400 | -33.3% | 0.00% | – |
Q3 2016 | $19,000 | -80.4% | 600 | -79.9% | 0.00% | -100.0% |
Q2 2016 | $97,000 | -92.8% | 2,981 | -93.9% | 0.00% | -91.7% |
Q1 2016 | $1,356,000 | +545.7% | 48,500 | +725.5% | 0.01% | +500.0% |
Q4 2015 | $210,000 | – | 5,875 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |